Zura Bio Limited
NASDAQ:ZURA · NASDAQ Capital Market
+$0.07 today
Vol 1.27M · Avg 0.75M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+234.82%
Period High
$7.04
Period Low
$1.05
Latest
$3.75
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Assembly Biosciences, Inc.
NASDAQ:ASMB
$387.23M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$290.79M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$280.21M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$243.37M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$216.67M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$212.75M
Immuneering Corporation
NASDAQ:IMRX
$157.73M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$127.66M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$116.96M
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
$85.63M
What is the latest ZURA filing?
The latest filing shown is 8-K dated May 22, 2026.
How many recent filings does ZURA have?
Intrinsic Alpha currently shows 20 recent filings for ZURA.
Explore More
Continue the stock analysis
Jump to another research area for this company.